Several mutations (V521L, P525L, L528M, T532S, and V555I) in the gene for hepatitis B virus (HBV) polymerase have been identified in HBV isolated from patients that displayed break-through viremia during famciclovir treatment. To determine whether these mutations cause phenotypic resistance to famci
Evaluation of peptide nucleic acid array for the detection of hepatitis B virus mutations associated with antiviral resistance
โ Scribed by Young Jin Choi; Hong Soo Kim; Sae Hwan Lee; Joon Soo Park; Hae Seon Nam; Hwi Jun Kim; Chang Jin Kim; Dong Jun Jeong; Kwi Sung Park; Kyoung Ah Baek
- Publisher
- Springer Vienna
- Year
- 2011
- Tongue
- English
- Weight
- 288 KB
- Volume
- 156
- Category
- Article
- ISSN
- 1432-8798
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Adefovir has a potent antiviral activity as a rescue treatment against lamivudineโresistant strains. The aim of this study was to assess the patterns of lamivudineโresistant mutations and their influence on the virologic response to adefovir rescue therapy in patients with lamivudineโre
Lamivudine is effective in suppressing replication of hepatitis B virus (HBV). However, the emergence of HBV variants resistant to lamivudine is a concern. Lamivudine resistance has been attributed mainly to a substitution of isoleucine or valine for methionine at residue 550 (M550I or M550V) in the